Prognostic factors and outcome of HER2+ breast cancer with CNS metastases.
Masci G, Agostinetto E, Giordano L, Bottai G, Torrisi R, Losurdo A, De Sanctis R, Navarria P, Scorsetti M, Zuradelli M, de Rose F, Bello L, Santoro A.
Masci G, et al.
Future Oncol. 2020 Mar;16(7):269-279. doi: 10.2217/fon-2019-0602. Epub 2020 Feb 11.
Future Oncol. 2020.
PMID: 32043375